|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/14 | |
| C07D 401/04 | |||
| C07D 409/04 | |||
| C07D 409/14 | |||
| C07D 417/14 | |||
| A61K 31/4418 | |||
| A61K 31/444 | |||
| A61K 31/506 | |||
| A61P 3/00 | |||
| A61P 9/00 |
| (11) | Patento numeris | 3114121 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15710687.3 |
| Europos patento paraiškos padavimo data | 2015-03-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-01-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/018874 |
| Data | 2015-03-05 |
| (87) | Numeris | WO 2015/134701 |
| Data | 2015-09-11 |
| (30) | Numeris | Data | Šalis |
| 201461949506 P | 2014-03-07 | US |
| (72) |
MENG, Wei, US
ZHAO, Guohua, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | DIHYDROPYRIDINONE MGAT2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS |
| DIHYDROPYRIDINONE MGAT2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS |